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Abstract
Background: The characterization of small lesions in cirrhotic patients is extremely difficult due to the overlap of
imaging features among different entities in the step-way of the hepatocarcinogenesis. The aim of our study was to
evaluate the role of gadoxetic-acid MRI in the differentiation of small (≤2 cm) well-differentiated hepatocellular
carcinomas from regenerative and dysplastic nodules.
Methods: Seventy-three cirrhotic patients, with 118 focal liver lesions (≤2 cm) were prospectively recruited. MRI
examination was performed with a 3T magnet and the study protocol included T1 - and T2-weighted pre-contrast
sequences and T1 -weighted gadoxetic-acid enhanced post-contrast sequences obtained during the arterial, venous,
late dynamic and hepatobiliary phases. All lesions were pathologically confirmed. Two radiologists blinded to clinical
and pathological information evaluated two imaging datasets; another radiologist analysed the signal intensity
characteristics of each lesion. Sensitivity, specificity and diagnostic accuracy were considered for statistical analysis.
Results: Good agreement was reported between the two readers (κ 0.70). Both readers reported a significantly
improved sensitivity (57.7 and 66.2 vs 74.6 and 83.1) and diagnostic accuracy (0.717 and 0.778 vs 0.843 and 0.
901) with the adjunction of the hepatobiliary phase 57.7 vs 74.6 and 66.2 vs 83.1 (p ≤ 0.04).
Conclusions: Gadoxetic-acid MRI is a reliable tool for the characterization of HCC and lesions at high risk to
further develop.
Keywords: Regenerative nodule, Dysplastic nodule, Well-differentiated HCC, Magnetic resonance, Liver specific
contrast agent
Background
Hepatocellular carcinoma (HCC) occurs primarily in sub-
jects with chronic liver disease or liver cirrhosis and is the
cause of death in this population. The development of HCC
may arise from de novo hepatocarcinogenesis or by means
of a multistep progression from regenerative nodule,
through dysplastic nodule to HCC [1, 2]. Especially for small
nodules, it is sometimes very difficult to characterize a liver
lesion due to the overlap of imaging features among differ-
ent entities especially between dysplastic nodules and well-
differentiated HCCs. Magnetic resonance imaging (MRI)
has shown a poor diagnostic performance in this setting
with a sensitivity ranging from 55 to 72 % [3, 4]. With the
introduction of hepatobiliary system–specific contrast media
in clinical practice, MRI can improve the detection and
characterization of liver tumours with a sensitivity value ran-
ging from 72 to 92 % [4–6]. Gadoxetic acid is a paramag-
netic, gadolinium-based contrast medium that combines
perfusion and hepatocyte-selective properties. In a single
examination, gadoxetic acid enables the standard dynamic
MRI study of the liver and the evaluation of the functional
liver tissue, due to the uptake of approximately 50 % of the
contrast agent by the hepatocytes [7]. The role of a liver spe-
cific contrast agent in the detection of HCC in cirrhotic liver* Correspondence: micdimartino@hotmail.it
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has been well established in the literature, but definitive data
on the role of MRI in the “grey zone” of the hepatocarcino-
genesis (regenerative nodule, dysplastic nodule and well-
differentiated HCC) are still partially lacking [8, 9]. The pur-
pose of the present study is to distinguish well-differentiated
HCCs from regenerative nodules and dysplastic nodules
using gadoxetic acid MRI, mainly focused at the hepatobili-
ary phase.
Methods
Patient population
This prospective study was approved by the Institutional
Review Board of “Sapienza” University of Rome, Depart-
ment Radoiological Sciences, Oncology and Anatomical
Pathology and followed the principles of the 1964 Declar-
ation of Helsinki and subsequent amendments. Informed
consent was obtained from all individual participants in-
cluded in the study. Between January 2014 and July 2015,
230 consecutive patients with chronic liver disease were
evaluated prospectively within the Liver Unit of the De-
partment of Gastroenterology for the examination of their
pathology and the evaluation of suspected lesion at Ultra-
sound. Among these, 157 patients were excluded from
data analysis for the following reasons: 1) absence of focal
lesion at MR exam n° = 35; 2) focal lesion greater than
2 cm n° = 37; 3) lack of histologically proven lesion n° =
57; 4) inadequate specimen for pathological analysis at
liver biopsy n° = 15; and 5) moderate/high grade of HCC n
° = 13. The inclusion criteria were focal liver lesions ≤
2 cm in diameter and their histological confirmation. The
final study population was composed of seventy-three pa-
tients (47 males – 26 females; mean age 64 years; range
23–82 years), with 118 focal liver lesions (Fig. 1). Histo-
logical information had been obtained by liver transplant-
ation, surgery and liver biopsy according to the best
clinical care for the patient. Liver biopsy was mainly per-
formed for the characterization of nodules with MRI pat-
terns that were not suggestive of HCC (wash-in and wash-
out), and in a few cases of HCC with typical aspects, a
liver biopsy was performed before radiofrequency ablation.
Patients who had undergone surgery or biopsy were
followed by CT or MR examinations with a surveillance
interval of 6 months [10]. Chronic hepatitis or cirrhosis
were related to viral infection (hepatitis C [n° = 31], hepa-
titis B [n° = 13], both [n° = 2]), alcohol abuse (n° = 7), alco-
hol +HCV infection (n° = 11) or cryptogenic (n° = 9).
Forty patients were Child-Pugh A classified, 22 were class
B, and 11 were class C.
MRI technique
MRI was performed using a 3 Tesla scanner (Discovery
MR750; General Electric Systems, Milwaukee, Wisconsin,
US) equipped with a high-performance gradient system
(50 mT/m). Signal reception was achieved using a com-
bined antero-posterior phased-array surface coil and a
spine array coil. MRI sequences and parameters are de-
tailed in Table 1.
Timing for the initial post-contrast arterial phase ac-
quisition was determined using an automated bolus
detection technique (SmartPrep, General Electric) [11].
The full 0.025 mmol/kg body weight dose of gadoxetic-
acid (Primovist Bayer Schering Pharma, Berlin, Germany:
0.1 mL/kg body weight) was administered at the flow rate
of 2 mL/sec through an 18–22-gauge intravenous catheter
by means of a power injector (Spectris; Medrad, Indianola,
Pa), followed by a 20-mL saline flush at the same injection
rate. Post contrast images were obtained ≈ 25, 70, and
180 s after contrast medium injection, during the hepatic
arterial, hepatic venous, and late dynamic phases, re-
spectively, as well as during the hepatobiliary phase
Fig. 1 Flowchart of the enrolment of the study population based on recommended standards for reporting diagnostic accuracy and proof of
tumour burden
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(20 min after contrast medium administration). Before
the administration of gadoxetic-acid, a respiratory-
triggered single-shot echo-planar imaging DWI MR
sequence was also acquired with b values of 0, 50,
400 and 800 s/mm2. A spectral attenuated inversion-
recovery technique was used for fat suppression of
DW images.
Image analysis
One radiologist (with 3 years of experience in liver im-
aging), who was not involved in the data set analysis,
evaluated the signal intensity of each lesion at all ac-
quired sequences (precontrast, dynamic and hepatobili-
ary phases) as hyperintense, isointense, or hypointense
relative to liver parenchyma. Two data sets of images were
generated: a) pre-contrast sequences + dynamic phase se-
quences and b) pre-contrast sequences + dynamic phase
sequences + hepatobiliary phase sequences.
All data sets of images were independently
reviewed by two radiologist experts in abdominal
MRI (C.C. 18 years, M.D.M. 10 years), in two reading ses-
sions with a time interval of four weeks to avoid any recall
bias, by using a commercially available workstation (Leo-
nardo; Siemens Medical Systems) with standard interpret-
ation tools (window width, pan, level). The readers were
blinded to the results of histopathologic analysis. HCC
was unequivocally diagnosed if it was hypervascular dut-
ing the hepatic arterial phase and fulfilled any one of the
following five criteria: (a) hypointensity compared with
the surrounding liver during portal venous or late dy-
namic phases (wash-out sign), (b) peripheral rim enhance-
ment during the late dynamic phase (capsular
appearence), (c) invasion line of adjacent vessels, and (d)
hypointensity during the hepatobiliary phase. In addition,
suggestive but non-conclusive criterion of HCC included
(a) mild hyperintensity on T2-weighted MR images or (b)
nodular early enhancement without washout.
Pathologic analysis
All resected and explanted livers were analysed by the
same experienced (30 years of experience) pathologist.
They were sectioned in the axial plane with a slice
thickness of 5–10 mm. The MRI images had been dir-
ectly correlated with histological findings by an expert
radiologist (10 years of experience in abdominal im-
aging) who was present when the specimens were pre-
pared for evaluation. Percutaneous needle nodule biopsy
was performed with an 18-gauge needle, under local
anaesthesia and ultrasound guidance. Each biopsy speci-
men was approximately 1.5 cm in length. No complica-
tions, such as bleeding and/or seeding, were reported
after liver biopsy. The diagnosis of hepatocellular nod-
ules was performed according to criteria of the Inter-
national Working Party on haematoxylin and eosin
(H&E)-stained sections supplemented by CD34 immu-
nostaining for nodule vascularization. Criteria for the
differentiation of HCC from dysplastic nodule were
tumour invasion into portal tracts (stromal invasion)
and presence of multi-foci of neo-angiogenesis [12, 13].
Statistical analysis
Inter-reader variability between the readers for lesion
detection was assessed by using the weighted κ statistic.
K values of 0.4 or less were considered positive but fair
agreement, those of 0.41–0.60 moderate agreement,
those of 0.61–0.80 a good agreement and greater than
0.80 indicated an excellent agreement [14]. The accuracy
of each imaging method was determined using a
jackknife alternative, free-response receiver operating
characteristic (JAFROC_v3b_BETA), considering fixed
readers and random cases [15]. The area under each
curve (AUC) was used to indicate the overall diagnostic
performance of each reader on each image set. Determi-
nations of the sensitivity, specificity, and positive and
negative predictive values (PPV and NPV, respectively)
for lesion detection on each image set for each reader
were calculated against reference standard findings. The
95 % confidence interval (CI) was also calculated for
each evaluation. To consider the possible presence of
multiple lesions within the same patient, the significance
of differences in sensitivity and PPV among the different
image sets was assessed using a generalized linear mixed
model with P values calculated using an adjustment
of the McNemar test [16]. Statistical analyses were
Table 1 MR imaging sequences and parameters
MR Sequence Fat suppression TR/TE
(OP/IP) (ms)
Flip angle
(degrees)
Section
thickness (mm)
Matrix size Bandwidth
(Hz/pixel)
Field of
view (cm)
Time (s)
T2-weighted 2D
SSFSE
w/ and w/out 3000/110 90 5 320 × 324 260 30–40 32
T1-weighted 2D
dual GRE
Not used 4/1.2–2.4 12 5 320 × 324 260 30–40 32
SS-EPI-DWI Used 5455/77 90 6 100 × 192 250 30–40 30
T1-weighted 3D
GRE LAVAa
Used 4.2/1.3 12 5
(interpolated 2.5)
320 × 224 250 30–40 23
aAcquired before and after contrast medium administration during the arterial (≈25 s), venous (70 s.), late dynamic (180 s.) and hepatobiliary phases (20 min)
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conducted using dedicated software (SPSS version
13.0, SPSS, Chicago, Ill, US).
Results
Qualitative analysis
Among the 118 identified lesions (1 to 4 per patient), 71
in 52 patients were well-differentiated HCC (range 5–
20 mm; median 15 mm) of which 32 were confirmed at
liver transplantation, 15 at surgery and 24 at biopsy; 25
lesions in 15 patients were dysplastic nodules (range 5–
20 mm, median 15 mm), of which 14 were confirmed at
liver transplantation, 6 at surgery and 5 at biopsy. Add-
itionally, 22 in 18 patients were regenerative nodules
(range 6–20 mm; median 15 mm) of which 16 were
confirmed at liver transplantation and 6 at biopsy. MRI
appearance of regenerative, dysplastic nodules and well-
differentiated HCC at different MRI sequences are
summarized in Table 2. Well-differentiated HCC showed
the typical imaging pattern (wash-in and wash-out) in
43/71 lesions (60.5 %), 16/71 (21.1 %) were hypervascu-
lar without wash-out and 12/71 (16.9 %) were hypoin-
tense during the arterial phase with loss of signal
intensity during the late dynamic phase (Fig. 1). During
the hepatobiliary phase, six typical HCCs showed uptake
of the contrast medium (13.9 %); by contrast among
hypervascular lesions without wash out, 7 nodules out of
16 (43.7 %) showed loss of signal intensity during the
hepatobiliary phase, which means that there is an ab-
sence of functional hepatocytes and that it should be
considered a sign of malignancy. All hypovascular HCCs
reported a loss of signal intensity during the late dy-
namic phase, and four of these were isointense during
the hepatobiliary phase. Additionally, 35 out of 71
(50.7 %) of the well-differentiated HCCs, mostly HCCs
with the typical imaging pattern, were hyperintense on
T2-weighted images. Data of Low Grade Dysplastic
Nodules (LGDN) and High Grade Dysplastic Nodules
(HGDN) were pooled because only 7 cases of LGDN out
of 29 were identified. Dysplastic nodules, in most cases,
appeared as a nodule without enhancement (hypo- or
isointense) during the arterial phase and were relatively
hypointense during the late dynamic phase 20/25 (80 %).
Among these, 7 (40 %) were hypointense during the
hepatobiliary phase (Fig. 2). Eight dysplastic nodules,
confirmed at liver biopsy and showing a loss of signal in-
tensity on both late dynamic and hepatobiliary phases,
subsequently developed the typical imaging pattern of
HCC (wash-in and wash-out) within 6–12 months. In
four cases (16 %) confirmed at liver transplantation, dys-
plastic nodules demonstrated the typical pattern of HCC
and represented the main cause of false positive calls.
None of the dysplastic nodules were hyperintense on
T2-weighted images and most of them (20/25, 80 %)
were hypointense to the surrounding liver parenchyma:
in effect at histological examination some iron particles
were found within the nodules. Regenerative nodules
tend to be isointense to liver parenchyma in all pre-
contrast and post-contrast dynamic phases. Only 4 out
of 22 nodules (18.8 %) were hypervascular during the ar-
terial phase (Fig. 3) and 2 lesions were slightly hypoin-
tense during the delayed phase. One lesion out of two
showed high signal intensity on hepatobiliary phase and
none of the regenerative nodules reported low signal in-
tensity during the hepatobiliary phase. The other regen-
erative nodules were localized because they were
hyperintense on T1-weighted images 6/22 (27.3 %) and/
or slightly hypointense on T2-weighted images 10/22
(45.5 %) and/or 10/22 (45.5 %) hyperintense on hepato-
biliary phase. Diagnostic performance regarding the de-
tection of HCC showed a good inter-reader agreement
(κ .70) between the two observers. Both readers detected
significantly more malignant lesions on MRI datasets
that included pre-contrast, dynamic and hepatobiliary
phases than on MRI datasets that included only pre-
contrast and dynamic phases (57.7 and 66.2 vs 74.6 and
83.1 : p = 0.049 and p = 0.03) (Table 3). The overall
accuracy for the detection of HCC was higher on dy-
namic + hepatobiliary phase MRI for both readers
compared to dynamic MRI alone, and both radiologists
reported a significant difference (0.717 and 0.778 vs 0.843
and 0.901: p = 0.03) (Table 3). The hepatobiliary phase was
useful for a definitive diagnosis of malignancy in 7 of 16
cases (43.7 %): these nodules showed enhancement during
the arterial phase and no wash-out sign during the venous
and late dynamic phase.
Both the PPV and NPV for HCC identification were
higher on dynamic + hepatobiliary phases MRI compared
to dynamic phases MRI alone (Table 3).
Table 2 Signal intensities of different lesions at each MR sequence
T1-w T2-w T1-Art T1-Ven T1-LD T1-Hepatobiliary
Well diff. HCC - 57,7 hyper
(27/45)
53.3 hyper
(24/45)
82.2 hyper
(37/45)
64.4 iso
(29/45)
66.6 hypo
(30/45)
84.2 hypo
(38/45)
D.N. - 55,1 hyper
(16 /29)
58.6 hypo
(17/29)
58.6 iso/hypo
(25/29)
68 hypo
(17/29)
89.6 hypo
(26 /29)
58.6 iso/hyper
(17/29)
R.N. - 51 iso / hyper
(17/33)
75.7 iso
(25/33)
57.7 iso
(19/33)
87.8 iso
(29/33)
84.8 iso
(28/33)
100 iso / hyper
(33/33)
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Fig. 2 MR scans in a patient with chronic hepatitis, HCV related, and HCC and dysplastic nodule in liver segment V. a-b T2- and T1-weighted fast
images show a heterogeneous nodule in liver segment V (arrow). The lesion shows the typical pattern of HCC with enhancement during the
arterial phase c) and a wash-out sign on late dynamic phase d). On the late dynamic phase, a lesion near the “hilum-hepatis” is also detectable
with loss of signal intensity to the surrounding liver parenchyma (open arrow). e On the fat-suppressed T1 -weighted 3D GRE image obtained
during the hepatobiliary phase at 20 min after contrast injection, both lesions are hypointense to the surrounding liver parenchyma. f Histological
analysis shows a hepatocellular carcinoma (upper image) and dysplastic nodule (lower image)
Fig. 3 MR scans in a patient with chronic hepatitis, HCV related, and a regenerative nodule in liver segment VIII. a-b T1 - and T2-weighted images
do not reveal any focal liver lesion. c T1-weighted gradient-echo shows a hypervascular lesion without wash-out during the late dynamic phase
d). On the corresponding MR image obtained during the liver-specific hepatobiliary phase (e), the lesion is isointense to adjacent hepatic parenchyma.
At pathologic examination of the explanted liver, this lesion corresponded to a multiacinar cirrhotic nodule
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Discussion
Our experience confirmed that Gadoxetic acid MRI is a
reliable tool for the identification of HCC or lesions at
high risk of developing into HCC. Loss of signal intensity
during the hepatobiliary phase helps to improve the detec-
tion of small (≤20 mm) hypervascular well-differentiated
HCCs without washout during the dynamic phases. With
the development of fast sequences and the acquisition of
images at different vascular phases, MRI has demon-
strated a trend to a better sensitivity and accuracy over
CT, and with the introduction in clinical practice of liver
specific contrast agent, this difference has become more
significant [17, 18]. At present, indeed, MRI is considered
the best imaging approach in the evaluation of nodules in
cirrhotic patients. However, the detection and
characterization of small HCC in cirrhotic patients is still
challenging because it is difficult to distinguish HCC from
other entities that could develop in cirrhotic liver. Consid-
ering imaging patterns of the three groups of lesions that
were mentioned in the study (well-differentiated HCC,
dysplastic nodule and regenerative nodule) at dynamic
phases, HCCs tend to have a typical imaging pattern in
60.5 % of cases. In 14 out of 71 cases (19 %), HCC appears
as isointense lesions with wash-out signs. This imaging
pattern suggests that tumour neo-angiogenesis starts after
the disruption of peri-portal space [19, 20]. The main fea-
ture of dysplastic nodules was hypovascular lesion (iso/
hypointense) with a loss of signal intensity during the late
dynamic phase. This is probably because in the dysplastic
nodules there are only a few foci of neo-angiogenesis and
the blood is drained to the sinusoid by the surrounding
liver parenchyma, but it could also be explained by the
early uptake of the gadoxetic acid from the liver paren-
chyma near the lesion. Ten dysplastic nodules showed a
loss of signal intensity on both late dynamic and hepato-
biliary phases. These image findings overlapped in our
study population with some hypovascular HCCs. Eight of
those dysplastic nodules changed their imaging patterns
to that of HCC at follow-up imaging. Loss of signal inten-
sity on both the late dynamic and hepatobiliary phase
should then be considered a high feature of malignancy
and could predict malignant transformation, and a more
intensive management would be required (strict follow-up
or biopsy) [21–23]. As suggested by previously published
papers, in our experience, gadoxetic-acid MRI significantly
increases sensitivity and diagnostic accuracy in the detec-
tion of small hepatocellular carcinoma. [24–27]. In our ex-
perience, a high signal intensity on T2 should be certainly
considered a sign of malignant transformation because it
was encountered only in HCCs, although with a poor de-
tection rate (53.3 %) [28]. Our study certainly has some
limits. Firstly, in our study we considered low grade and
high grade dysplastic nodules in the same group due to
the small number of low grade dysplastic nodules. We are
aware that there is a significant difference between these
two entities in developing HCC. Secondly, some histo-
logical confirmations were obtained with liver biopsy,
which in small nodules may lead to a small amount of
sampling tissue and difficult nodule characterization. Fi-
nally, although DWI MRI sequence is a part of the MRI
protocol at our institution, data were not reported in this
paper because the preliminary results showed no signifi-
cant differences of adding DW images for the detection of
HCC. The role of DW images in cirrhotic liver is still a
matter of debate. Some authors emphasize that it is
useful for the detection and characterization of nod-
ules in cirrhotic liver [29], while others affirm that it
only slightly increases MRI sensitivity [30, 31].
Conclusion
In our experience, loss of signal intensity at gadoxetic
acid MRI hepatobiliary phase is a reliable tool in the
identification of HCC and lesions at high risk to develop
into HCC. Cirrhosis-associated hepatocellular nodules
with non specific findings at MR imaging, that show loss
of signal intensity during the hepatobiliary phase should
undergone more intensive management.
Abbreviation
DN: Dysplastic nodule; DWI: Diffusion weighted imaging; HCC: Hepatocellular
carcinoma; HGDN: High grade dysplastic nodules; LGDN: Low grade dysplastic
nodules; MRI: Magnetic resonance imaging; RN: Regenerative nodule
Table 3 Diagnostic performance for HCC detection
Sensitivity Specificity Positive predictive value Negative predictive value Accuracy
Observer 1 Dynamic phases 57.7 %(41/71)
[.45–.69]
91.5 %(43/47)
[.80–.97]
91.1 %(41/45)
[.78–.97]
58.9 %(43/73)
[.49–.71]
0.717
[.60–.83]
Dynamic + hept phases *74.6 %(53/71)
[.61–.83]
91.5 %(43/47)
[.80–.97]
92.9 %(53/57)
[.79–.97]
70.5 %(43/61)
[.53–.75]
§0.843
[.73–.95]
Observer 2 Dynamic phases 66.2 %(47/71)
[.54–.77]
91.5 %(43/47)
[.80–.97]
92.2 %(47/51)
[.85–.98]
62.7 %(42/67)
(54/85)
0.778
[.64–.88]
Dynamic + hept phases *83.1 %(59/71)
[.72–.91]
95.7 %(45/47)
[.85–.99]
96.7 %(59/61)
[.87–.98]
78.9 %(45/57)
[.52–.73]
§0.901
[.78–.99]
Numbers in brackets are the 95 % CIs
*Significantly higher sensitivity for both readers p = 0.04 and p = 0.03
§Significantly higher sensitivity for both readers p = 0.03
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